Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Investment Co Pjsc Mubadala currently holds 14,561,742 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Investment Co Pjsc Mubadala has been a net seller of RXRX stock. They have purchased $65.0M and sold $1.2B worth of shares.
Investment Co Pjsc Mubadala's most recent insider trade was on Jul 29, 2025, when they purchased 773,328 shares at $24.16 per share.
Investment Co Pjsc Mubadala serves as Executive at RECURSION PHARMACEUTICALS, INC. (RXRX). They have executed 17 insider transactions totaling $1.3B over their tenure at the company.
Investment Co Pjsc Mubadala holds the position of Executive at RECURSION PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Investment Co Pjsc Mubadala has shown a selling trading pattern, with $65.0M in total purchases and $1.2B in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Investment Co Pjsc Mubadala was on Feb 5, 2019, when they sold $817.9M worth of AMD shares. This transaction involved 34,906,166 shares at $23.43 per share.
Investment Co Pjsc Mubadala currently owns 14,561,742 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Investment Co Pjsc Mubadala's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Investment Co Pjsc Mubadala has 17 Form 4 filings on record as an insider at RECURSION PHARMACEUTICALS, INC..
Set alerts for Investment Co Pjsc Mubadala and 40,000+ other insiders.